CClinicalTrials.gg
RecruitingNCT07165834Updated May 4, 2026

Voices of Transformation: A Deep Dive Into the Struggles and Successes of Reclaiming Sexuality After Sexual Trauma

An interventional study of Treatment group. "Take your sexuality back" in Sexual Abuse, Posttraumatic Stress Symptom and Sexual Trauma, sponsored by Sykehuset Telemark. Recruiting at 1 site in Norway. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by Sykehuset Telemark · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

This study aims to gain insight into the experiences of participants in the "Take Your Sexuality Back" intervention groups, evaluate the intervention's acceptability, and identify necessary modifications. This study is part of a larger project that seeks to establish a scientific basis for this innovative, group-based treatment to help women who have experienced sexual trauma heal their sexuality. Before implementing the intervention in the healthcare system and initiating a larger randomized controlled trial, the investigators will evaluate the intervention's feasibility and potential efficacy, as well as gain a more comprehensive understanding of treatment outcomes. In addition to collecting quantitative data, it is crucial to gather qualitative data on participants' experiences. In this study, data will be obtained through in-depth interviews with group participants after they complete the intervention.

02

Conditions studied

  • Sexual Abuse
  • Posttraumatic Stress Symptom
  • Sexual Trauma

Browse trials for

03

In context

Sexual Trauma

21 studies on the registry are indexed under Sexual Trauma; 7 are open to participants now.

This study's planned enrollment of 20 is below the median of 33 across 18 interventional studies indexed under Sexual Trauma.

Browse Sexual Trauma studies →

Lead sponsor

Sykehuset Telemark is the lead sponsor of 32 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  1. A history of sexual trauma
  2. Experience trauma-related sexual problems
  3. Age between 18 and 65 years
  4. Enough competence in Norwegian to participate in a psychoeducational group.

Exclusion criteria

Exclusion Criteria:

  1. Acute suicidality
  2. Serious substance abuse interfering with treatment
  3. Severe dissociative or psychotic disorders
  4. Current life crisis interfering with treatment
  5. Living in an abusive relationship. -
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Treatment group. "Take your sexuality back"

    "Take your sexuality back" is a 12 week group intervention for sexually traumatized women.

    Behavioral: Treatment group. "Take your sexuality back"

Interventions

  • BehavioralTreatment group. "Take your sexuality back"

    The intervention is trauma-sensitive and focus both on traumatized sexuality and positive sexuality. It incorporates regulatory skills to prevent re-traumatization when addressing sex-positive themes, thus accommodating a wide range of trauma-related symptoms, sexual shame, sexual dysfunctions, and regulation difficulties. The intervention integrates psychoeducation, exercises, reflections and sharing.

06

What researchers measure

Primary outcomes

  1. What are the participants lived experiences of participating in the group intervention "Take your sexuality back"

    In-depth interviews investigating participants experiences and perceptions of the intervention, and how they react to any positive or negative impacts attributed to it. Interviews will be analyzed through a descriptive phenomenological method.

    Time frame: 1-2 weeks after end of treatment

07

Study locations

1 of 1 sites recruiting
  • Sykehuset Telemark HF
    Skien, Norway
    • Malin Wästlund, PhD-student · Contact · malin.wastlund@nenett.no · 0047-95135546
    • Idun Røseth, PhD · Principal investigator
    • Malin C. Wästlund, PhD-student · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Qualitative data are sensitive and participant anonymity cannot be guaranteed.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07165834
Lead sponsor
Sykehuset Telemark
Collaborators
University of Agder, Norwegian University of Science and Technology
Responsible party
Idun Røseth (Head of research, Sykehuset Telemark) — Principal investigator
First posted
Sep 10, 2025
Start date
Sep 15, 2025
Primary completion
Sep 2026 (estimated)
Completion
Dec 2028 (estimated)
Last update
May 4, 2026

Study contacts

Idun Røseth, PhD
Contact
iduroe@sthf.no
+4741200462
Siv Åshild Billington
Contact
Siv.Ashild.Billington@sthf.no
0047-97777857
Hege Kersten, PhD
study director · Research and Innovation Manager

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion